ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance

JACC: Cardiovascular Interventions

Volumn 7, Issue 7, 2014, Pages 741-750

  Mattesini, Alessio ^a,b   Secco, Gioel G ^a,c   Dall'Ara, Gianni ^a   Ghione, Matteo ^a   Rama Merchan, Juan C ^a   Lupi, Alessandro ^c   Viceconte, Nicola ^a   Lindsay, Alistair C ^a   De Silva, Ranil ^a   Foin, Nicolas ^d   Naganuma, Toru ^e   Valente, Serafina ^b   Colombo, Antonio ^e   Di Mario, Carlo ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b Department of Heart and Vessels AOUC Careggi ^*  (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

^e EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

bioresorbable vascular scaffold; drug eluting stent; optical coherence tomography; stent

Indexed keywords

POLYMER; LACTIC ACID; METAL; POLYLACTIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON; BIORESORBABLE SCAFFOLD; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL STENT; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; TISSUE INJURY; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DEVICES; ITALY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROSTHESIS; PROSTHESIS FAILURE; RADIOGRAPHY; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED KINGDOM;

ABSORBABLE IMPLANTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; LACTIC ACID; LONDON; MALE; METALS; MIDDLE AGED; POLYMERS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84905057410     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.01.165     Document Type: Article

References (30)

1. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
2. J. Fan, H. Du, and Y. Yin et al. Efficacy and safety of zotarolimus-eluting stents compared with sirolimus-eluting stents in patients undergoing percutaneous coronary interventions-a meta-analysis of randomized controlled trials Int J Cardiol 167 2013 2126 2133
3. N. Foin, S. Sen, and E. Allegria et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention 8 2013 1315 1325
4. P.W. Serruys, Y. Onuma, and J.A. Ormiston et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
5. P.W. Serruys, J.A. Ormiston, and Y. Onuma et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
6. J.A. Ormiston, P.W. Serruys, and E. Regar et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907 (Pubitemid 351384734)
7. G.J. Tearney, E. Regar, and T. Akasaka et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J Am Coll Cardiol 59 2012 1058 1072
8. N. Viceconte, P.H. Chan, and E.A. Barrero et al. Frequency domain optical coherence tomography for guidance of coronary stenting Int J Cardiol 166 2013 722 728
9. J.F. Diaz, A. Gomez-Menchero, and R. Cardenal et al. Extremely high-pressure dilation with a new noncompliant balloon Tex Heart Inst J 39 2012 635 638
10. J. Gomez-Lara, R. Diletti, and S. Brugaletta et al. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study EuroIntervention 8 2012 214 224
11. P. Barlis, K. Dimopoulos, and J. Tanigawa et al. Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage Int J Cardiol 141 2010 151 156
12. F. Prati, G. Guagliumi, and G.S. Mintz et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures Eur Heart J 33 2012 2513 2520
13. N. Foin, R. Torii, and P. Mortier et al. Kissing balloon or sequential dilation of the side branch and main vessel for provisional stenting of bifurcations: lessons from micro-computed tomography and computational simulations J Am Coll Cardiol Intv 5 2012 47 56
14. S. Sonoda, Y. Morino, and J. Ako et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the Sirius trial J Am Coll Cardiol 43 2004 1959 1963 (Pubitemid 38686788)
15. M.A. Costa, D.J. Angiolillo, and M. Tannenbaum et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial) Am J Cardiol 101 2008 1704 1711
16. K. Fujii, S.G. Carlier, and G.S. Mintz et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study J Am Coll Cardiol 45 2005 995 998 (Pubitemid 40432428)
17. H. Doi, A. Maehara, and G.S. Mintz et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials J Am Coll Cardiol Intv 2 2009 1269 1275
18. A.C. Lindsay, M. Paulo, and K. Kadriye et al. Predictors of stent strut malapposition in calcified vessels using frequency-domain optical coherence tomography J Invasive Cardiol 25 2013 429 434
19. N. Gonzalo, P.W. Serruys, and H.M. Garcia-Garcia et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries Rev Esp Cardiol 62 2009 615 624
20. H.G. Song, S.J. Kang, and J.M. Ahn et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus- and sirolimus-eluting stent implantation Catheter Cardiovasc Interv 83 2014 873 878
21. J.P. Oberhauser, S. Hossainy, and R.J. Rapoza Design principles and performance of bioresorbable polymeric vascular scaffolds EuroIntervention 5 Suppl F 2009 F15 F22
22. S. Brugaletta, J. Gomez-Lara, and R. Diletti et al. Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials Catheter Cardiovasc Interv 79 2012 219 228
23. M.K. Hong, G.S. Mintz, and C.W. Lee et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up Circulation 113 2006 414 419 (Pubitemid 43803203)
24. R. Hoffmann, M.C. Morice, and J.W. Moses et al. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials Heart 94 2008 322 328 (Pubitemid 351303424)
25. S. Cook, P. Wenaweser, and M. Togni et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434 (Pubitemid 46717965)
26. J. Tanigawa, P. Barlis, and K. Dimopoulos et al. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
27. P. Tyczynski, G. Ferrante, and C. Moreno-Ambroj et al. Simple versus complex approaches to treating coronary bifurcation lesions: direct assessment of stent strut apposition by optical coherence tomography Rev Esp Cardiol 63 2010 904 914
28. N. Viceconte, P. Tyczynski, and G. Ferrante et al. Immediate results of bifurcational stenting assessed with optical coherence tomography Catheter Cardiovasc Interv 81 2013 519 528
29. Y. Onuma, P.W. Serruys, and L.E. Perkins et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
30. Y.J. Hong, M.H. Jeong, and Y. Ahn et al. Incidence, predictors, and clinical impact of tissue prolapse after stent implantation for saphenous vein graft disease: intravascular ultrasound study Int J Cardiol 168 2013 3073 3075